These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 1706346)

  • 1. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells.
    Sistonen L; Koskinen PJ; Lehväslaiho H; Lehtola L; Bravo R; Alitalo K
    Oncogene; 1990 Jun; 5(6):815-21. PubMed ID: 1972791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P; Lehväslaiho H; MacDonald-Bravo H; Alitalo K; Bravo R
    Oncogene; 1990 Apr; 5(4):615-8. PubMed ID: 1970155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H; Sistonen L; diRenzo F; Partanen J; Comoglio P; Hölttä E; Alitalo K
    J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
    New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Jul; 11(2):271-9. PubMed ID: 7542762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses.
    Pandiella A; Lehvaslaiho H; Magni M; Alitalo K; Meldolesi J
    Oncogene; 1989 Nov; 4(11):1299-305. PubMed ID: 2573029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
    Qian X; Dougall WC; Hellman ME; Greene MI
    Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A; Gusella GL; Radzioch D; Varesio L
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
    Cao H; Decker S; Stern DF
    Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.